Shot in the arm or a shot in the dark? Complacency fears over Covid-19 vaccine equity market boost

Market rally too premature, experts warn

Mike Sheen
Value stocks fared best throughout the week following news of Pfizer's vaccine breakthrough

Value stocks fared best throughout the week following news of Pfizer's vaccine breakthrough

The equity market rally sparked by news of Pfizer's Covid-19 vaccine breakthrough last week may have been "over the top", with significant hurdles still ahead for investors, despite growing confidence among value-focused fund groups that their investment style may finally be about to break its losing streak.

Equity markets globally climbed higher on reports that Pfizer's vaccine could be imminently available, as investors saw hope the coronavirus-inspired economic slowdown could soon be nearing its end. Value stocks fared best throughout the week, with the MSCI World Value index up 1.5% in the four days since the announcement, compared to gains of 0.7% for the MSCI World and a marginal decline for the MSCI World Growth index, according to data from FE fundinfo. There were notable market moves for high-profile stocks, with British Airways owner IAG's share price climbing almost 40% immedia...

To continue reading this article...

Join Investment Week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on Global

Industry Voice: PIMCO Secular Outlook

Industry Voice: PIMCO Secular Outlook

Reaching for Resilience

clock 28 June 2022 • 2 min read
Market Movers Blog: S&P 500 slides into bear market

Market Movers Blog: S&P experiences worst H1 since 1970

Latest news and analysis

Investment Week
clock 27 June 2022 • 1 min read
David Kimberley is an investment trusts writer at Kepler & Partners

Opportunity amid madness: Valuations more attractive in wake of panic-driven price drops

Buy opportunities have arisen

David Kimberley
clock 21 June 2022 • 4 min read